123 related articles for article (PubMed ID: 32231272)
1. SNP rs17079281 decreases lung cancer risk through creating an YY1-binding site to suppress DCBLD1 expression.
Wang Y; Ma R; Liu B; Kong J; Lin H; Yu X; Wang R; Li L; Gao M; Zhou B; Mohan M; Yu H; Hou Z; Shen H; Qian B
Oncogene; 2020 May; 39(20):4092-4102. PubMed ID: 32231272
[TBL] [Abstract][Full Text] [Related]
2. Positional integration of lung adenocarcinoma susceptibility loci with primary human alveolar epithelial cell epigenomes.
Yang C; Stueve TR; Yan C; Rhie SK; Mullen DJ; Luo J; Zhou B; Borok Z; Marconett CN; Offringa IA
Epigenomics; 2018 Sep; 10(9):1167-1187. PubMed ID: 30212242
[TBL] [Abstract][Full Text] [Related]
3. Transcription Factor YY1 Modulates Lung Cancer Progression by Activating lncRNA-PVT1.
Huang T; Wang G; Yang L; Peng B; Wen Y; Ding G; Wang Z
DNA Cell Biol; 2017 Nov; 36(11):947-958. PubMed ID: 28972861
[TBL] [Abstract][Full Text] [Related]
4. miR‑29a suppresses IL‑13‑induced cell invasion by inhibiting YY1 in the AKT pathway in lung adenocarcinoma A549 cells.
Zhang Y; He S; Mei R; Kang Y; Duan J; Wei R; Xiang C; Wu Y; Lu X; Cai Z; Xiong L
Oncol Rep; 2018 Jun; 39(6):2613-2623. PubMed ID: 29620222
[TBL] [Abstract][Full Text] [Related]
5. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.
Meyer KB; Maia AT; O'Reilly M; Ghoussaini M; Prathalingam R; Porter-Gill P; Ambs S; Prokunina-Olsson L; Carroll J; Ponder BA
PLoS Genet; 2011 Jul; 7(7):e1002165. PubMed ID: 21814516
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of STIM1 expression inhibits non-small-cell lung cancer cell proliferation
Ge C; Zeng B; Li R; Li Z; Fu Q; Wang W; Wang Z; Dong S; Lai Z; Wang Y; Xue Y; Guo J; Di T; Song X
Bioengineered; 2019 Dec; 10(1):425-436. PubMed ID: 31564210
[TBL] [Abstract][Full Text] [Related]
7. A Common Variant at the 14q32 Endometrial Cancer Risk Locus Activates AKT1 through YY1 Binding.
Painter JN; Kaufmann S; O'Mara TA; Hillman KM; Sivakumaran H; Darabi H; Cheng THT; Pearson J; Kazakoff S; Waddell N; Hoivik EA; Goode EL; Scott RJ; Tomlinson I; Dunning AM; Easton DF; French JD; Salvesen HB; Pollock PM; Thompson DJ; Spurdle AB; Edwards SL
Am J Hum Genet; 2016 Jun; 98(6):1159-1169. PubMed ID: 27259051
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA MUC5B-AS1 promotes metastasis through mutually regulating MUC5B expression in lung adenocarcinoma.
Yuan S; Liu Q; Hu Z; Zhou Z; Wang G; Li C; Xie W; Meng G; Xiang Y; Wu N; Wu L; Yu Z; Bai L; Li Y
Cell Death Dis; 2018 May; 9(5):450. PubMed ID: 29670111
[TBL] [Abstract][Full Text] [Related]
9. DCBLD1 is associated with the integrin signaling pathway and has prognostic value in non-small cell lung and invasive breast carcinoma.
Cardin GB; Bernard M; Rodier F; Christopoulos A
Sci Rep; 2021 Jun; 11(1):12753. PubMed ID: 34140574
[TBL] [Abstract][Full Text] [Related]
10. Risk SNP-Mediated Enhancer-Promoter Interaction Drives Colorectal Cancer through Both
Tian J; Lou J; Cai Y; Rao M; Lu Z; Zhu Y; Zou D; Peng X; Wang H; Zhang M; Niu S; Li Y; Zhong R; Chang J; Miao X
Cancer Res; 2020 May; 80(9):1804-1818. PubMed ID: 32127356
[TBL] [Abstract][Full Text] [Related]
11. Integrative Genomic Analysis Predicts Causative
Zhang Y; Manjunath M; Zhang S; Chasman D; Roy S; Song JS
Cancer Res; 2018 Apr; 78(7):1579-1591. PubMed ID: 29351903
[TBL] [Abstract][Full Text] [Related]
12. Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR-AKT-mTOR signaling.
Lee KY; Shueng PW; Chou CM; Lin BX; Lin MH; Kuo DY; Tsai IL; Wu SM; Lin CW
Cancer Sci; 2020 May; 111(5):1652-1662. PubMed ID: 32133706
[TBL] [Abstract][Full Text] [Related]
13. Weak sharing of genetic association signals in three lung cancer subtypes: evidence at the SNP, gene, regulation, and pathway levels.
O'Brien TD; Jia P; Caporaso NE; Landi MT; Zhao Z
Genome Med; 2018 Feb; 10(1):16. PubMed ID: 29486777
[TBL] [Abstract][Full Text] [Related]
14. SNP rs9387478 at ROS1-DCBLD1 Locus is Significantly Associated with Lung Cancer Risk and Poor Survival in Indian Population.
Chongtham J; Pandey N; Sharma LK; Mohan A; Srivastava T
Asian Pac J Cancer Prev; 2022 Oct; 23(10):3553-3561. PubMed ID: 36308382
[TBL] [Abstract][Full Text] [Related]
15. C10ORF97 is a novel tumor-suppressor gene of non-small-cell lung cancer and a functional variant of this gene increases the risk of non-small-cell lung cancer.
Shi Y; Chen J; Li Z; Zhang Z; Yu H; Sun K; Wang X; Song X; Wang Y; Zhen Y; Yang T; Lou K; Zhang Y; Zhang G; Hu Y; Ji J; Hui R
Oncogene; 2011 Sep; 30(39):4107-17. PubMed ID: 21499297
[TBL] [Abstract][Full Text] [Related]
16. [Association between a novel regulatory genetic variants and lung cancer risk in Chinese: a two-stage case-control study].
Zhu XQ; Si NP; Fu XY; Cheng JW; Qin N; Liu YC; Tian T; Ma HX; Chu MJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Nov; 42(11):2053-2059. PubMed ID: 34818854
[No Abstract] [Full Text] [Related]
17. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
Ma S; Wang X; Zhang Z; Liu D
Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants in histone modification regions are associated with the prognosis of lung adenocarcinoma.
Kang HG; Lee YH; Lee SY; Choi JE; Do SK; Hong MJ; Lee JH; Jeong JY; Do YW; Lee EB; Shin KM; Lee WK; Choi SH; Seo HW; Yoo SS; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Park JY
Sci Rep; 2021 Nov; 11(1):21520. PubMed ID: 34728688
[TBL] [Abstract][Full Text] [Related]
19. Semaphorin 5A suppresses the proliferation and migration of lung adenocarcinoma cells.
Ko PH; Lenka G; Chen YA; Chuang EY; Tsai MH; Sher YP; Lai LC
Int J Oncol; 2020 Jan; 56(1):165-177. PubMed ID: 31789397
[TBL] [Abstract][Full Text] [Related]
20. miR-212-5p exerts tumor promoter function by regulating the Id3/PI3K/Akt axis in lung adenocarcinoma cells.
Chen FF; Sun N; Wang Y; Xi HY; Yang Y; Yu BZ; Li XJ
J Cell Physiol; 2020 Oct; 235(10):7273-7282. PubMed ID: 32039486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
